MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 1 filers reported holding MINERVA NEUROSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $76,000 | -5.0% | 91,355 | -8.8% | 0.00% | – |
| Q4 2021 | $80,000 | -75.8% | 100,161 | -47.3% | 0.00% | – |
| Q3 2021 | $331,000 | -55.1% | 190,056 | -40.2% | 0.00% | -100.0% |
| Q2 2021 | $737,000 | +171.0% | 317,652 | +241.0% | 0.00% | – |
| Q1 2021 | $272,000 | +15.3% | 93,143 | -7.6% | 0.00% | – |
| Q4 2020 | $236,000 | +165.2% | 100,807 | +258.6% | 0.00% | – |
| Q3 2020 | $89,000 | -76.3% | 28,111 | -73.0% | 0.00% | – |
| Q2 2020 | $375,000 | +197.6% | 103,968 | +538.0% | 0.00% | – |
| Q3 2019 | $126,000 | -72.1% | 16,295 | -79.7% | 0.00% | -100.0% |
| Q2 2019 | $452,000 | -47.4% | 80,125 | -26.8% | 0.00% | 0.0% |
| Q1 2019 | $860,000 | +40.1% | 109,399 | +20.0% | 0.00% | 0.0% |
| Q4 2018 | $614,000 | -14.0% | 91,190 | +60.2% | 0.00% | 0.0% |
| Q3 2018 | $714,000 | +79.4% | 56,932 | +26.7% | 0.00% | 0.0% |
| Q2 2017 | $398,000 | +87.7% | 44,931 | +71.9% | 0.00% | – |
| Q1 2017 | $212,000 | -57.4% | 26,139 | -46.4% | 0.00% | -100.0% |
| Q2 2016 | $498,000 | – | 48,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 449,500 | $1,429,000 | 0.58% |
| Opaleye Management Inc. | 767,400 | $2,440,000 | 0.48% |
| FRAZIER MANAGEMENT LLC | 550,000 | $1,749,000 | 0.16% |
| FEDERATED HERMES, INC. | 9,610,200 | $30,560,000 | 0.07% |
| Artal Group S.A. | 760,000 | $2,417,000 | 0.06% |
| ARMISTICE CAPITAL, LLC | 500,000 | $1,590,000 | 0.06% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 63,114 | $201,000 | 0.04% |
| Cormorant Asset Management, LP | 238,817 | $759,000 | 0.03% |
| ACADIAN ASSET MANAGEMENT LLC | 1,705,195 | $5,423,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 419,104 | $1,333,000 | 0.01% |